Nutrivert Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $2.37M

  • Investors
  • 8

Nutrivert General Information

Description

Operator of a biotechnology company intended to provide an alternative to livestock antibiotics. The company's postbiotics is a formulation of a feed additive that increases livestock feed conversion efficiency and selectively kills the bacteria that are susceptible to antibiotics, enabling customers to get improved output from their livestock and to control bacterial diseases in them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2525 Peachtree Road NorthEast
  • Suite 27
  • Atlanta, GA 30305
  • United States
+1 (404)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2525 Peachtree Road NorthEast
  • Suite 27
  • Atlanta, GA 30305
  • United States
+1 (404)

Nutrivert Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nutrivert Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A2) 29-Apr-2026 $2.37M Completed Clinical Trials - General
7. Later Stage VC (Series A) 06-Mar-2023 Completed Startup
6. Accelerator/Incubator 03-Feb-2021 Completed Startup
5. Grant 01-Oct-2020 Completed Startup
4. Accelerator/Incubator 14-Feb-2020 Completed Startup
3. Accelerator/Incubator 07-Mar-2018 Completed Startup
2. Grant 01-May-2017 $23.8K Completed Startup
1. Grant 01-Jan-2017 $39K Completed Startup
To view Nutrivert’s complete valuation and funding history, request access »

Nutrivert Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A 250,100 $0.001000 $6 $6 1x $6 9.23%
To view Nutrivert’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nutrivert Patents

Nutrivert Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025006896-A1 Low dose muramyl dipeptide analogue-containing compositions and methods of using same for immunoprotection Inactive 29-Jun-2023
AU-2021241625-A1 Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity Active 26-Mar-2020
AU-2021241625-B2 Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity Active 26-Mar-2020
CA-3172936-A1 Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity Pending 26-Mar-2020
EP-4126040-A1 Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity Active 26-Mar-2020 C07K5/06026
To view Nutrivert’s complete patent history, request access »

Nutrivert Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nutrivert Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cultiv8 Funds Management Venture Capital Minority
Plug and Play Accelerator/Incubator Minority
Cade Museum Other
SparkLabs Group Venture Capital Minority
Cultivation Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Nutrivert FAQs

  • When was Nutrivert founded?

    Nutrivert was founded in 2016.

  • Where is Nutrivert headquartered?

    Nutrivert is headquartered in Atlanta, GA.

  • What is the size of Nutrivert?

    Nutrivert has 3 total employees.

  • What industry is Nutrivert in?

    Nutrivert’s primary industry is Drug Discovery.

  • Is Nutrivert a private or public company?

    Nutrivert is a Private company.

  • What is the current valuation of Nutrivert?

    The current valuation of Nutrivert is .

  • What is Nutrivert’s current revenue?

    The current revenue for Nutrivert is .

  • How much funding has Nutrivert raised over time?

    Nutrivert has raised $3.98M.

  • Who are Nutrivert’s investors?

    Cultiv8 Funds Management, Plug and Play, Cade Museum, SparkLabs Group, and Cultivation Capital are 5 of 8 investors who have invested in Nutrivert.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process